Health care ETF XLV rises 17.6% in 2026 and nears record highs
The Health Care Select Sector SPDR ETF (XLV), which groups the S&P 500 health care companies, is up 17.6% in 2026 versus 13.7% for the broader index. The equal-weighted RSPH gains 24.3%. Pharmaceutical companies such as Eli Lilly, Johnson & Johnson, AbbVie and Merck are driving the rally, while medical device makers fall. XLV trades at about 19.3 times expected earnings.
In 30 seconds
- XLV is up 17.6% in 2026, above the S&P 500's 13.7%, while the equal-weighted RSPH gains 24.3%.
- Health care providers and biotech ETFs gain 26.6% and 25.8%, while the medical devices ETF falls 12.3%.
- Eli Lilly raised second-quarter revenue 48% to US$23 billion on Mounjaro and Zepbound.
IASummary generated by artificial intelligence from a story by XTB.com. It may contain errors: the original source prevails.




Comments
Be respectful. Comments reported by several people are hidden until a moderator reviews them.
You do not need an account to read, only to comment. Sign in with a code sent to your email or with your Google account. We only show the name you choose, never your email.